Cargando…

Molecular docking analysis of calcium channel blockers with ALR2 and RAGE

A metabolic condition called diabetes mellitus is linked to a number of substantial challenges. Advanced Glycation End Products (AGEs) and Aldose reductase (ALR2) are crucial in the slow development of several secondary complications. Selected calcium channel blockers (CCB's-1, 4-dihydropyridin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazmi, Samreen, Challa, Surekha, Alaparthi, Malini Devi, M, Indira Devi, Nagamalla, Swetha Sudha, EJ, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504517/ https://www.ncbi.nlm.nih.gov/pubmed/37720280 http://dx.doi.org/10.6026/97320630019028

Ejemplares similares

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Morpho-Physiological and Proteomic Response of Bt-Cotton and Non-Bt Cotton to Drought Stress
por: Nagamalla, Swetha Sudha, et al.
Publicado: (2021)

Molecular docking analysis of an isoflavone derivative with the protein phosphatase 1 from Leishmania donovani
por: Qureshi, Rahila, et al.
Publicado: (2020)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Conceptual DFT, QTAIM, and Molecular Docking Approaches to Characterize the T-Type Calcium Channel Blocker Anandamide
por: Rangel-Galván, Maricruz, et al.
Publicado: (2022)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Prevalence of gingival enlargement secondary to calcium channel blockers in patients with cardiovascular diseases
por: Pedaballi, Priya, et al.
Publicado: (2012)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Docking Studies of Phthalimide Pharmacophore as a Sodium Channel Blocker
por: Iman, Maryam, et al.
Publicado: (2013)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

How far can we go in precision with ALR?
por: Blondel, A
Publicado: (1990)

Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis Pigmentosa
por: Nakazawa, Mitsuru
Publicado: (2011)

Regulation of Alr1 Mg Transporter Activity by Intracellular Magnesium
por: Lim, Phaik Har, et al.
Publicado: (2011)

The Aspartate-Less Receiver (ALR) Domains: Distribution, Structure and Function
por: Maule, Andrew F., et al.
Publicado: (2015)

Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008)

Prognostic factors of acute calcium-channel blocker poisonings
por: Karyo, S, et al.
Publicado: (2008)

Bio-Inspired Voltage-Dependent Calcium Channel Blockers
por: Yang, Tingting, et al.
Publicado: (2013)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Abdullah, Hannan Safiyyah Tan Sian Hui, et al.
Publicado: (2021)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Calcium Channel Blocker Toxicity: A Practical Approach
por: Alshaya, Omar A, et al.
Publicado: (2022)

Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers
por: Rajagopal, Sudarshan, et al.
Publicado: (2023)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway
por: Imran, Aqeel, et al.
Publicado: (2022)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Correction: The Aspartate-Less Receiver (ALR) Domains: Distribution, Structure and Function
Publicado: (2015)

Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers
por: Xu, Guanlan, et al.
Publicado: (2012)

Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine
por: Aburawi, SM, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0o6b3ddq5gblbcradlbr9da0o4